Home › Funds › DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt › ABBV

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt position in ABBV

ABBVIE INC · Health Care

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt reported holding 3,846,731 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$1.01B, representing 1.24% of its reported portfolio and ranking #22 among its reported holdings. DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.85M sh
Reported value held$1.01B
Portfolio Weight1.24%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt's ABBV position evolved

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt first disclosed a stake in ABBV in Q3 2023 at 2,656,500 shares (US$397.4M). The position peaked in Q4 2025 at 8,919,066 shares, worth US$2.04B. Across 13 filings, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,846,731 shares valued at US$1.01B — an increase of 961,174 shares quarter over quarter.. Notable position changes include a 105% increase in Q2 2024 (shares rose 16% over the following quarter), a 169% increase in Q2 2025 (shares rose 26% over the following quarter), a 164% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.66M $397.40M New
Q4 2023 2.66M $409.47M Hold
Q1 2024 2.66M $483.22M Hold
Q2 2024 5.44M $933.24M Add
Q3 2024 1.98M $389.30M Reduce
Q4 2024 1.37M $243.52M Reduce
Q1 2025 1.75M $367.43M Add
Q2 2025 4.72M $876.66M Add
Q3 2025 6.49M $1.50B Add
Q4 2025 8.92M $2.04B Add
Q1 2026 1.09M $237.34M Reduce
Q2 2026 2.89M $726.12M Add
Q3 2026 3.85M $1.01B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt held ABBV?

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt's current position in ABBV?

As of Q3 2026, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt holds 3.85M shares of ABBV (ABBVIE INC), valued at $1.01B, representing 1.24% of its reported portfolio and ranking #22.

Has DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt been buying or selling ABBV?

In the latest 13F filing (Q3 2026), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt increased its position in ABBV. The position peaked in Q4 2025 at 8.92M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.